<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8-antibiotics-09-00909">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bowen</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Carapetis</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Currie</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Fowler</surname>
    <given-names>V.</given-names>
    <suffix>Jr.</suffix>
   </name>
   <name>
    <surname>Chambers</surname>
    <given-names>H.F.</given-names>
   </name>
   <name>
    <surname>Tong</surname>
    <given-names>S.Y.C.</given-names>
   </name>
  </person-group>
  <article-title>Sulfamethoxazole-trimethoprim (cotrimoxazole) for skin and soft tissue infections including impetigo, cellulitis, and abscess</article-title>
  <source>Open Forum Infect. Dis.</source>
  <year>2017</year>
  <volume>4</volume>
  <fpage>ofx232</fpage>
  <pub-id pub-id-type="doi">10.1093/ofid/ofx232</pub-id>
  <pub-id pub-id-type="pmid">29255730</pub-id>
 </element-citation>
</ref>
